VC Catalog · venture ecosystem research library
VC Catalog home Beta

Company

Signacor

Rocket Ship RatingBased on the data VC Catalog holds.

Rocket Ship Rating: 77 out of 100

SignaCor, a UK based, clinical stage biotech company are pioneering a first-in-class therapeutic approach to symptomatic hypertrophic cardiomyopathy (HCM)

  • Biotech & therapeutics
Status
Operatingas of 2026-09-19
Business model
B2B
Headquarters
United Kingdom
Founded
2024
Open relationship map
Claim, correct or request removal

Record updated 28 September 2026

About

SignaCor is a clinical-stage biotech company focused on discovering, developing, and commercialising first-in-class cardiac therapeutics to deliver reach patient impact.

Products

Other
Cardiaza
Loading relationship preview

Cookies on VC Catalog

We use necessary cookies to run the site (sign-in, security, remembering this choice). With your permission we also use Google Analytics to understand how the site is used. Analytics cookies are set only if you accept all cookies. Privacy policy